HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis
HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis have?
HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis has 6 citations in the OpenAlex counts ScholarIQ stores.
When was HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis published?
HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis has 2021 year in the ScholarIQ index.
What is the open-access status of HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis?
HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis has gold oa status in the ScholarIQ index.
What is the DOI of HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis?
The DOI for HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis is on the source record.
What is the PMID of HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis?
The PMID for HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis is on the source record.
What is the OpenAlex record for HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis?
The OpenAlex for HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis is on the source record.